Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation

Brain Research

Volumn 998, Issue 2, 2004, Pages 184-193

  Blackburn, Annie ^a   Dewar, Karen ^a   Bauco, Pat ^a   Rompré, Pierre Paul ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Amphetamine; Locomotion; Neurotensin; Prefrontal cortex; Sensitization

Indexed keywords

AMPHETAMINE; IBOTENIC ACID; NEUROTENSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; LOCOMOTION; MALE; MOBILIZATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSITIZATION; TRAINING;

EID: 1642534518     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.11.022     Document Type: Article

References (36)

1. Bjijou Y., Stinus L., Le Moal M., Cador M. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J. Pharmacol. Exp. Ther. 277:1996;1177-1187.
2. 11]neurotensin and amphetamine. Abstr. Soc. Neurosci. 24:1998;994.
3. Boudin H., Pelaprat D., Rostene W., Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373:1996;76-89.
4. Cador M., Bjijou Y., Cailhol S., Stinus L. D-Amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience. 94:1999;705-721.
5. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20:2000;3864-3873.
6. Christie M.J., Bridge S., James L.B., Beart P.M. Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res. 333:1985;169-172.
7. 1-like receptors in the ventral tegmental area. Eur. J. Pharmacol. 336:1997;155-158.
8. During M.J., Bean A.J., Roth R.H. Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci. Lett. 140:1992;129-133.
9. Fatigati M.D., Anderson R.M., Rompre P.P. Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing. Brain Res. 876:2000;196-200.
10. Gariano R.F., Groves P.M. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res. 462:1988;194-198.
11. Hertel P., Mathe J.M., Nomikos G.G., Iurlo M., Mathe A.A., Svensson T.H. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 72:1995;103-114.
12. Jaskiw G.E., Karoum F., Freed W.J., Phillips I., Kleinman J.E., Weinberger D.R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res. 534:1990;263-272.
13. Kalivas P.W. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat: II. Involvement of the mesolimbic dopamine system. J. Pharmacol. Exp. Ther. 235:1985;544-550.
14. Kalivas P.W., Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10:1990;2940-2949.
15. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brains Res. Rev. 16:1991;223-244.
16. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1988;1095-1102.
17. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4:1993;315-334.
18. Leith N.J., Kuczenski R. Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology (Berl.). 76:1982;310-315.
19. Li Y., Wolf M.E. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav. Brain Res. 84:1997;285-289.
20. Lu X.Y., Churchill L., Kalivas P.W. Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse. 25:1997;205-214.
21. Nicot A., Rostene W., Berod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J. Comp. Neurol. 341:1994;407-419.
22. Panayi F., Dorso E., LambasSenas L., Renaud B., Scarna H., Berod A. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine. Neuropsychopharmacology. 26:2002;64-74.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
24. Rompré P.-P. Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine. Eur. J. Pharmacol. 328:1997;131-134.
25. Rompré P.-P., Perron S. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization. Neuropharmacology. 2000;1880-1892.
26. Rompré P.-P., Boye S.M., Moisan J. Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing. Eur. J. Pharmacol. 341:1998;169-172.
27. Rossetti Z.L., Marcangione C., Wise R.A. Increase of extracellular glutamate and expression of Fos-like immunoreactivity in the ventral tegmental area in response to electrical stimulation of the prefrontal cortex. J. Neurochem. 70:1998;1503-1512.
28. Santucci V., Gueudet C., Steinberg R., Le Fur G., Soubrie P. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade. Synapse. 26:1997;370-380.
29. Seroogy K.B., Mehta A., Fallon J.H. Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain. Exp. Brain Res. 68:1987;277-289.
30. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320:1992;145-160.
31. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290:1989;213-242.
32. Studler J.M., Kitabgi P., Tramu G., Herve D., Glowinski J., Tassin J.P. Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons. Neuropeptides. 11:1988;95-100.
33. Tzschentke T.M., Schmidt W.J. Differential effects of discrete subarea-specific lesions of the rat medial prefrontal cortex on amphetamine- and cocaine-induced behavioural sensitization. Cereb. Cortex. 10:2000;488-498.
34. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16:1996;2411-2420.
35. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
36. Wolf M.E., Dahlin S.L., Hu X.-T., Xue C.-J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with n-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.